A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity.

Nakagama, Yu; Nitahara, Yuko; Kaku, Natsuko; Tshibangu-Kabamba, Evariste; Kido, Yasutoshi

Nakagama, Yu; Nitahara, Yuko; Kaku, Natsuko; Tshibangu-Kabamba, Evariste; Kido, Yasutoshi.

Nakagama Y; Department of Parasitology, Osaka City Universitygrid.261445.0, Osaka, Japan.
Nitahara Y; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka City Universitygrid.261445.0, Osaka, Japan.
Kaku N; Department of Parasitology, Osaka City Universitygrid.261445.0, Osaka, Japan.
Tshibangu-Kabamba E; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka City Universitygrid.261445.0, Osaka, Japan.
Kido Y; Department of Parasitology, Osaka City Universitygrid.261445.0, Osaka, Japan.

J Clin Microbiol ; 60(2): e0226221, 2022 02 16.

Article in English | MEDLINE | ID: covidwho-1759278

Subject(s)

COVID-19; SARS-CoV-2; Antibodies, Viral; Antibody Affinity; Humans; Immunoglobulin M; Sensitivity and Specificity

Keywords

COVID-19; SARS-CoV-2; avidity maturation; serological assay

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study Limits: Humans Language: English Journal: J Clin Microbiol Year: 2022 Document Type: Article Affiliation country: Jcm.02262-21

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google